TheRecover.com, Attention Deficit Disorder Medication
May 07, 2018 23:14 pm UTC| Business
SAN DIEGO, May 07, 2018 -- Attention-Deficit Hyperactivity Disorder (ADHD) is a neurological disorder that presents itself through the symptoms of inattentiveness, hyperactivity, and impulsiveness. ADHD is commonly...
May 07, 2018 23:00 pm UTC| Business
WYOMISSING, Pa., May 07, 2018 -- Gaming and Leisure Properties, Inc. (the “Company” or “GLPI”) (NASDAQ:GLPI) today announced the pricing of its previously announced public offering of $1,000,000,000 aggregate principal...
May 07, 2018 23:00 pm UTC| Business
LA JOLLA, Calif., May 07, 2018 -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced...
Sabina Gold & Silver Announces Interim Financial Results for the Quarter Ended March 31, 2018
May 07, 2018 22:58 pm UTC| Business
$86 million in cash and short-term investments, pre-development activities commenced VANCOUVER, British Columbia, May 07, 2018 -- Sabina Gold Silver Corp. (“Sabina”) or (the “Company”) (TSX:SBB) reports the interim...
May 07, 2018 22:36 pm UTC| Business
BUENA, N.J., May 07, 2018 -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Deutsche Bank’s 43rd Annual Health Care Conference. The Conference is taking...
Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Newly Diagnosed Multiple Myeloma
May 07, 2018 22:36 pm UTC| Business
Company Announcement DARZALEX (daratumumab) approved by U.S. FDA in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for...
Sabra Restructures its Contractual Relationship with Signature HealthCARE
May 07, 2018 22:33 pm UTC| Business
IRVINE, Calif., May 07, 2018 -- Sabra Heath Care REIT, Inc. (Nasdaq:SBRA) (Nasdaq:SBRAP) (“Sabra”, “we” or the “Company”) announced today that it has entered into definitive agreements to restructure the Company’s...